Earnings Call · Q2 FY2024·2024-08-08

Q2 24EPS -6.06%·Rev n/aQ1 24EPS -100.00%*·Rev n/aQ4 23EPS +77.78%·Rev n/aQ3 23EPS +7.41%·Rev n/a⚠ consensus missing

CAPRICOR THERAPEUTICS, INC. CAPR

AJ Bergmann — Chief Financial Officer

Linda Marban — Chief Executive Officer

−9.0%1d on move date−8.3% vs SPY3d−3.8%5d+0.5%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CAPR calls or request research access.

More CAPR calls Browse calls Request research access